Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996
暂无分享,去创建一个
D. Snydman | S. Gorbach | S. Jenkins | N. Jacobus | L. Mcdermott | L. Harrell | D. Hecht | S. Supran | S. Finegold | J. Rihs | G. Cuchural | C. Pierson | P. Iannini | L. McDermott
[1] D. Snydman,et al. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] D. Snydman,et al. ANALYSIS OF THE IN VITRO ACTIVITY OF TROVAFLOXACIN (CP‐99,219) AGAINST BACTEROIDES SPECIES , 1996 .
[3] D. Snydman,et al. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] R. Nichols,et al. Wound and intraabdominal infections: microbiological considerations and approaches to treatment. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] I. Brook,et al. Clinical relevance of susceptibility testing of anaerobic bacteria. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] D. Snydman,et al. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis , 1992, Antimicrobial Agents and Chemotherapy.
[7] Y. Gluzman,et al. Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636 , 1990, Antimicrobial Agents and Chemotherapy.
[8] H. Wexler,et al. Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-beta-lactamase mediated cefoxitin resistance. , 1990, The Journal of antimicrobial chemotherapy.
[9] D. Snydman,et al. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. , 1990, The Journal of antimicrobial chemotherapy.
[10] N. Jacobus,et al. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group , 1990, Antimicrobial Agents and Chemotherapy.
[11] F. Tally,et al. Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase , 1990, Antimicrobial Agents and Chemotherapy.
[12] N. Jacobus,et al. In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms. , 1989, The Journal of antimicrobial chemotherapy.
[13] N. Jacobus,et al. Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation , 1988, Antimicrobial Agents and Chemotherapy.
[14] L. Piddock,et al. Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility. , 1987, The Journal of antimicrobial chemotherapy.
[15] M. Malamy,et al. Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis , 1986, Antimicrobial Agents and Chemotherapy.
[16] D. Smee,et al. Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells , 1986, Antimicrobial Agents and Chemotherapy.
[17] S. Gorbach,et al. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States , 1985, Antimicrobial Agents and Chemotherapy.
[18] S. Gorbach,et al. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982 , 1984, Antimicrobial Agents and Chemotherapy.
[19] S. Mitsuhashi,et al. Properties of novel beta-lactamase produced by Bacteroides fragilis , 1983, Antimicrobial Agents and Chemotherapy.
[20] S. Gorbach,et al. Susceptibility of the Bacteroides fragilis group in the United States in 1981 , 1983, Antimicrobial Agents and Chemotherapy.
[21] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[22] J. Bartlett,et al. Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins , 1975, Antimicrobial Agents and Chemotherapy.
[23] J. Bartlett,et al. Anaerobic Infections: Old Myths and New Realities , 1974 .
[24] J. Bartlett,et al. Anaerobic infections. 1. , 1974, The New England journal of medicine.
[25] M. Rathore,et al. Renal and Splenic Abscess in A Previously Healthy Child , 1994 .
[26] D. Citron,et al. Wadsworth Anaerobic Bacteriology Manual , 1980 .
[27] M. Malamy,et al. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. , 1979, The Journal of infectious diseases.